Insiderhandel: Aufsichtsrat kauft Aktien von Ironwood Pharmaceuticals im Wert von 6.622.080$
Denner, Alexander J. - Aufsichtsrat - Tag der Transaktion: 2021-03-01...…
Börse:
10,252$
2,51%
Echtzeit-Aktienkurs Ironwood Pharmaceuticals Inc.
Bid:
10,161$
Ask:
10,343$
Nachrichten zur Ironwood Pharmaceuticals Inc. Aktie
Insiderhandel: Aufsichtsrat kauft Aktien von Ironwood Pharmaceuticals im Wert von 9.293.840$
Denner, Alexander J. - Aufsichtsrat - Tag der Transaktion: 2021-02-26...…
Insiderhandel: Aufsichtsrat kauft Aktien von Ironwood Pharmaceuticals im Wert von 9.560.000$
Denner, Alexander J. - Aufsichtsrat - Tag der Transaktion: 2021-03-02...…
Ironwood (IRWD) Q4 Earnings Beat on Solid Linzess Sales
Ironwood (IRWD) witnesses strong demand for Linzess in the fourth quarter. However, outlook for 2021 misses market expectations....…
Ironwood Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Pharmaceuticals Inc (IRWD) Q4 2020 Earnings Call Transcript
IRWD earnings call for the period ending December 31, 2020....…
Ironwood Pharmaceuticals profit, revenue top views
Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7…
Recap: Ironwood Pharmaceuticals Q4 Earnings
Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) remained unaffected after the company reported Q4 results.
Quarterly Results
Earnings per share increased 20.00% over the…
IRONWOOD PHARMACEUTICALS INC: 8-K Report
FORM 8-K...…
Ironwood Pharmaceuticals EPS beats by $0.07, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Pharmaceuticals Q4 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Pharmaceuticals CEO exit may be catalyst for sale, analyst says
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood CEO Steps Down Months After Clinical Trial Failure, Names Thomas McCourt As Interim Chief Executive
read more...…
IRONWOOD PHARMACEUTICALS INC: 8-K Report
FORM 8-K...…
IRONWOOD PHARMACEUTICALS INC: 8-K Report
FORM 8-K...…
IRONWOOD PHARMACEUTICALS INC: 8-K Report
FORM 8-K...…
IRONWOOD PHARMACEUTICALS INC: 8-K Report
FORM 8-K...…
Can Ironwood (IRWD) Run Higher on Rising Earnings Estimates?
Ironwood (IRWD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings…
Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Transcript
IRWD earnings call for the period ending September 30, 2020....…
Ironwood Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood (IRWD) Q3 Earnings Beat on Solid Linzess Sales
Ironwood (IRWD) witnesses strong demand for Linzess in the third quarter....…
Ironwood Pharma on the move after activist joins board
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Pharmaceuticals (IRWD) Tops Q3 Earnings and Revenue Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of 64.29% and 10.71%, respectively, for the quarter ended September 2020. Do the…
West Mining Corp. Closes Qualifying Transaction
Vancouver, British Columbia--(Newsfile Corp. - November 4, 2020) - West Mining Corp. (TSXV: WEST) ("West" or the "Company"; formerly Ironwood Capital Corp.) is…
Ironwood Pharmaceuticals Q3 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Capital Corp. Files Filing Statement Respecting Qualifying Transaction
Vancouver, British Columbia--(Newsfile Corp. - October 26, 2020) - Ironwood Capital Corp. (TSXV: IRN.P) ("Ironwood" or the "Company") is pleased to announce that…
Ironwood to End IW-3718 Development After Study Failure
Ironwoods (IRWD) pipeline candidate, IW-3718, fails to meet primary endpoint in a phase III study evaluating it in patients with…
Ironwood to cut 100 jobs after acid reflux drug fails study
Ironwood Pharmaceuticals Inc said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder…
Ironwood to cut 100 jobs after digestive disease drug fails study
Ironwood Pharmaceuticals Inc said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder…
Ironwood Pharma bails on IW-3718; shares down 30% premarket
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
IRONWOOD PHARMACEUTICALS INC: 8-K Report
FORM 8-K...…
Ironwood Is Worth A Look As A Speculative Investment
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Capital Corp. Provides Update Respecting Proposed Qualifying Transaction
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2020) - Ironwood Capital Corp. (TSXV: IRN.P) ("Ironwood" or the "Company") is pleased to provide an…
Surging Earnings Estimates Signal Upside for Ironwood (IRWD) Stock
Ironwood (IRWD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings…
Ironwood (IRWD) Q2 Earnings Beat on Solid Linzess Sales
Ironwood (IRWD) witnesses strong demand for Linzess in the second quarter. COVID-19 impacts enrollment in clinical studies....…
Ironwood Pharmaceuticals, Inc. 2020 Q2 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of 100.00% and 6.89%, respectively, for the quarter ended June 2020. Do the…
IRONWOOD PHARMACEUTICALS INC: 8-K Report
FORM 8-K...…
Ironwood Pharmaceuticals Q2 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood updates changes in IW-3718 Phase III program in gastroesophageal reflux disease
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Pharmaceuticals (IRWD) Looks Good: Stock Adds 7.6% in Session
Ironwood Pharmaceuticals (IRWD) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge…
Ironwood to Halt MD-7246 Development After Study Failure
Ironwoods (IRWD) pipeline candidate, MD-7246 fails to meet primary endpoint in a phase II study evaluating it in patients with…
AbbVie, Ironwood to discontinue experimental IBS drug
Shares of AbbVie Inc. were up 0.2% in premarket trading on Wednesday after the drugmaker and Ironwood Pharmaceuticals Inc.…
Ironwood Capital Corp. Announces Proposed Qualifying Transaction
Vancouver, British Columbia--(Newsfile Corp. - May 11, 2020) - Ironwood Capital Corp. (TSXV: IRN.P) ("Ironwood" or the "Company") is pleased…
Ironwood Pharmaceuticals, Inc. 2020 Q1 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ironwood Pharmaceuticals Inc (IRWD) Q1 2020 Earnings Call Transcript
IRWD earnings call for the period ending March 31, 2020....…
Ironwood Capital Corp. LOI with 1Five2 Tech Expires
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2020) - Ironwood Capital Corp. (TSXV: IRN.P) ("Ironwood" or the "Company") announces that…
Can Ironwood (IRWD) Keep the Earnings Surprise Streak Alive-
Ironwood (IRWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Ironwood (IRWD) Down 22.1% Since Last Earnings Report: Can It Rebound-
Ironwood (IRWD) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…
Ironwood Pharmaceuticals (IRWD) Presents At Barclays Global Healthcare Conference - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…